Lucid Diagnostics (LUCD) Notes Payables (2023 - 2026)

Lucid Diagnostics has reported Notes Payables for 4 years, with the latest figure at $25.2 million in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables fell 23.17% year-over-year to $25.2 million; the trailing twelve-month figure through Mar 2026 stood at $25.2 million (down 23.17% YoY), and the FY2025 full-year result was $24.0 million, up 29.03% from the prior year.
• Notes Payables for Q1 2026 stood at $25.2 million, up from $24.0 million in the prior quarter.
• The five-year high for Notes Payables was $32.8 million in Q1 2025, with the low at $10.2 million in Q3 2024.
• Historically, Notes Payables has averaged $18.1 million across 4 years, with a median of $14.5 million in 2023.
• Annual changes were most pronounced in 2024 — Notes Payables fell 29.61% — and 2025, when it jumped 149.62%.
• Lucid Diagnostics' Notes Payables stood at $14.0 million in 2023, then jumped by 33.33% to $18.6 million in 2024, then climbed by 29.03% to $24.0 million in 2025, then gained by 5.0% to $25.2 million in 2026.
• The last three Notes Payables figures came in at $25.2 million (Q1 2026), $24.0 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.